ArticleNucleic acids research2026
Computational evolution of poly(U) polymerase for efficient and controlled RNA oligonucleotide synthesis.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Template-independent polymerases such as poly(U) polymerase (PUP) hold promise for enzymatic RNA synthesis but are limited by inefficient incorporation of modified nucleotides. Here, we describe a multi-round, closed-loop workflow integrating Gaussian accelerated molecular dynamics (GaMD), machine learning (ML), and generative artificial intelligence (AI) to engineer PUP variants with enhanced activity and stability. Our engineering strategy commenced with a deep mechanistic analysis of PUP using GaMD simulations. This provided the blueprint for our first key step: engineering PUPdel, a truncated variant that achieved a pivotal breakthrough by incorporating 3'-terminally blocked nucleotides and enabling controlled template-independent synthesis. Subsequently, we screened single-point mutations using protein language models (e.g. ESM1v) combined with Rosetta-based stability predictions, yielding a 47.78% hit rate for functionally active variants. Iterative ML models predicted synergistic multi-mutant combinations, increasing success rates to 63%. Finally, ESM3-based generative design produced PUPdel2, with 16 mutations conferring 3.4°C higher thermostability, 3.7-fold improved expression, and up to 5.4-fold enhanced catalytic efficiency for 3'-O-allyl-UTP. Structural analyses revealed that mutations enhance β-trapdoor flexibility and substrate binding via electrostatic and dynamic mechanisms. This AI-driven approach navigates vast sequence space efficiently, enabling superior enzymes for biotechnological applications in RNA therapeutics and beyond.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.